Nvidia’s AI Lead Is Back in Focus as Wolfe Research Doubles Down

Nvidia posted Q4 fiscal 2026 revenue of $68.1B, up 73% year over year and above expectations, with data-center revenue hitting a record $62.3B, up 75%. Management said an "agentic AI inflection point has arrived," and Wolfe Research reiterated Outperform, calling NVDA its best pick in AI Infrastructure. The stock is at a fresh all-time high of $236.54, though analysts cite valuation and 2027 visibility as the main debate ahead of May 20 Q1 fiscal 2027 earnings.

Analysis

NVDA remains the cleanest way to express the second derivative of AI capex: not just more spend, but a shift from training-led bursts to a broader, more durable inference buildout. That matters because inference workloads are stickier and more embedded in enterprise workflows, which should reduce the air-pocket risk that typically follows a single hyperscaler order cycle. The market is starting to price Nvidia less like a semis vendor and more like a utility-like platform with optionality on software and rack-level integration, which helps explain why the multiple has stayed elevated even as the stock has already rerated sharply.

The bigger competitive implication is that Nvidia’s real moat is moving upstream into system design, networking, and deployment complexity. That raises the barrier for ASIC alternatives and weakens the argument that hyperscalers can fully internalize the stack in the near term, because switching costs now include software compatibility, orchestration, and time-to-deployment, not just chip economics. The beneficiaries outside NVDA are the supply-chain names with exposure to advanced packaging, high-speed interconnect, and power delivery; the losers are broad-based semi peers that depend on generic AI exposure without owning the full stack.

The key risk is not an earnings miss in the next quarter, but a credibility gap on the multi-year ramp: if management does not convincingly expand visibility beyond the near-term order book, the stock can de-rate fast from “best-in-class growth” to “good but fully owned.” Over the next few days, earnings are the main catalyst; over the next 3-12 months, watch for hyperscaler capex revisions, enterprise inference adoption, and any evidence that order timing is pulling demand forward rather than expanding it. The consensus seems to be underestimating how much of the upside is already embedded in estimate revisions, so the setup favors strength into the print but more asymmetric risk afterward if guidance lacks a fresh accelerant.

Key Decisions for Investors

• Stay long NVDA into earnings via a defined-risk structure: buy 1-2 month call spreads rather than outright stock to capture a post-print momentum squeeze while limiting downside if guidance disappoints. Best risk/reward is if implied move understates guidance upside.
• Pair long NVDA / short AMD over the next 1-3 months to isolate share gains in the highest-confidence AI platform name versus the more valuation-sensitive second-tier AI beneficiary. This works best if hyperscaler capex stays firm and buyers continue prioritizing ecosystem maturity over chip-level price/performance.
• Add a basket long in AI infrastructure enablers with better relative valuation, especially AVGO, ANET, and TSM, for 3-6 months. These names should benefit if the market broadens from GPU scarcity to rack-level deployment and networking bottlenecks.
• Take partial profits on any pre-earnings NVDA strength and re-enter on post-print volatility if the stock sells off on ‘already-owned’ concerns. The best entry is likely a 3-5% pullback that is not accompanied by capex downgrades from hyperscalers.
• Hedge the event with a small short in a broad semi ETF or basket, since the main downside scenario is not NVDA-specific failure but multiple compression across the AI complex if management fails to extend the runway.